Comparative Analysis of Neutrophil-to-lymphocyte Ratio, Systemic Immune-Inflammation Index, and Prognostic Nutritional Index in Acute Myocardial Infarction Patients Treated with Percutaneous Coronary Intervention

被引:6
|
作者
Kocas, Betul Balaban [1 ]
Cetinkal, Gokhan [1 ]
Ser, Ozgur Selim [1 ]
Yildiz, Suleyman Sezai [1 ]
Kilickesmez, Kadriye [1 ]
机构
[1] Prof Dr Cemil Tascioglu City Hosp, Dept Cardiol, Istanbul, Turkey
关键词
Acute myocardial infarction; neutrophil-to-lymphocyte ratio; prognostic nutritional index; systemic immune-inflammation index; THROMBOLYTIC THERAPY; ELDERLY-PATIENTS; MORTALITY; PREDICTS; OUTCOMES; ASSOCIATION; RISK;
D O I
10.5543/tkda.2022.22513
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Acute myocardial infarction constitutes one of the leading reasons for cardiac mortality. Therefore, early identification of high-risk patients provides better prognostic accuracy. This study aimed to investigate the prognostic significance of novel inflammatory biomarkers such as neutrophil-to-lymphocyte ratio, systemic immune-inflammation index, and prognostic nutritional index in acute myocardial infarction patients treated with percutaneous coronary intervention and to compare their predictive abilities with each other. Methods: A total of 828 acute myocardial infarction patients treated with percutaneous coronary intervention were retrospectively analyzed. The inflammatory indices, such as neutrophil-to-lymphocyte ratio, systemic immune-inflammation index, and prognostic nutritional index, were calculated by admission blood tests. The study population was divided into 2 groups according to the occurrence of major adverse cardiac events, which were defined as all-cause mortality, non-fatal myocardial infarction, and cerebrovascular events. Results: Multivariate Cox regression analysis determined prognostic nutritional index as an independent predictor of major adverse cardiac event and all-cause mortality (hazard ratio: 1.05, 95% CI: 1.02-1.07, P <.001 for major adverse cardiac event and hazard ratio: 1.05, 95% CI: 1.02-1.09, P =.002 for all-cause mortality). Receiver operating characteristic curves revealed that the predictive value of prognostic nutritional index with both regard to major adverse cardiac event and all-cause mortality was better than the systemic immune-inflammation index and neutrophil-to-lymphocyte ratio (by DeLong method, area under curve PNI vs. area under curve SII z test = 2.66, P =.008; area under curve PNI vs. area under curve NLR z test = 2.8, P =.006; area under curve PNI vs. area under curve SII z test = 2.58, P =.009; area under curve PNI vs. area under curve NLR z test = 3.28, P =.001; respectively). Conclusions: Prognostic nutritional index was demonstrated as an independent predictor of major adverse cardiac events and all-cause mortality and a more powerful prognostic index than other novel inflammatory biomarkers in acute myocardial infarction patients treated with percutaneous coronary intervention.
引用
收藏
页码:505 / 511
页数:7
相关论文
共 50 条
  • [41] Correction to: Prognostic value of the systemic immune-inflammation index, systemic inflammation response index, and prognostic nutritional index in head and neck cancer
    Ebru Atasever Akkas
    Eda Erdis
    Birsen Yucel
    European Archives of Oto-Rhino-Laryngology, 2023, 280 : 3831 - 3833
  • [42] Prognostic Nutritional Index Is Superior to Neutrophil-to-lymphocyte Ratio as a Prognostic Marker in Metastatic Breast Cancer Patients Treated With Eribulin
    Oba, Takaaki
    Maeno, Kazuma
    Ono, Mayu
    Ito, Tokiko
    Kanai, Toshiharu
    Ito, Ken-ichi
    ANTICANCER RESEARCH, 2021, 41 (01) : 445 - 452
  • [43] Comparison of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII) as marker of adverse prognosis in patients with infective endocarditis
    Thottuvelil, Sunil Roy
    Chacko, Manas
    Warrier, Anup R.
    Nair, Manoj P.
    Rajappan, Anil Kumar
    INDIAN HEART JOURNAL, 2023, 75 (06) : 465 - 468
  • [44] Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment
    Kubota, Kosei
    Ito, Ryohei
    Narita, Norihiko
    Tanaka, Yusuke
    Furudate, Ken
    Akiyama, Natsumi
    Chih, Chuang Hao
    Komatsu, Shotaro
    Kobayashi, Wataru
    BMC CANCER, 2022, 22 (01)
  • [45] The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage
    Wang, Rui-Hong
    Wen, Wan-Xin
    Jiang, Ze-Ping
    Du, Zhen-Ping
    Ma, Zhao-Hui
    Lu, Ai-Li
    Li, Hui-Ping
    Yuan, Fang
    Wu, Shi-Biao
    Guo, Jian-Wen
    Cai, Ye-Feng
    Huang, Yan
    Wang, Li-Xin
    Lu, Hong-Ji
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [46] Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment
    Kosei Kubota
    Ryohei Ito
    Norihiko Narita
    Yusuke Tanaka
    Ken Furudate
    Natsumi Akiyama
    Chuang Hao Chih
    Shotaro Komatsu
    Wataru Kobayashi
    BMC Cancer, 22
  • [47] Clinical Implication of Systemic Immune-Inflammation Index and Prognostic Nutritional Index in Skull Base Chordoma Patients
    Li, Mingxuan
    Bai, Jiwei
    Wang, Shuai
    Zhai, Yixuan
    Zhang, Shuheng
    Li, Chuzhong
    Du, Jiang
    Zhang, Yazhuo
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [48] Evaluation of systemic immune inflammation index and neutrophil-to-lymphocyte ratio in schizophrenia, bipolar disorder and depression
    Canli, Derya
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2024, 125 (08): : 472 - 476
  • [49] Predicting severity of inpatient acute cholangitis: combined neutrophil-to-lymphocyte ratio and prognostic nutritional index
    Dong Li
    Jingchao Sun
    Chao Qi
    Xifeng Fu
    Fei Gao
    BMC Gastroenterology, 24 (1)
  • [50] Utility of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune Inflammation Index as Prognostic, Predictive Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab and Ipilimumab
    Iinuma, Koji
    Enomoto, Torai
    Kawada, Kei
    Fujimoto, Shota
    Ishida, Takashi
    Takagi, Kimiaki
    Nagai, Shingo
    Ito, Hiroki
    Kawase, Makoto
    Nakai, Chie
    Kawase, Kota
    Kato, Daiki
    Takai, Manabu
    Nakane, Keita
    Kameyama, Koji
    Koie, Takuya
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (22)